Asymmetry Capital Management, L.P. - SIENNA BIOPHARMACEUTICALS IN ownership

SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 43 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Asymmetry Capital Management, L.P. ownership history of SIENNA BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q2 2018$372,000
-23.1%
24,516
-8.2%
0.37%
-44.3%
Q4 2017$484,000
-47.7%
26,692
-35.9%
0.66%
-38.8%
Q3 2017$926,00041,6221.07%
Other shareholders

There were no reported owners of SIENNA BIOPHARMACEUTICALS IN in Q4 2017.

NameSharesValueWeighting ↓
View complete list of SIENNA BIOPHARMACEUTICALS IN shareholders